Revvity | PKI - Selling And Administration Expenses

Stock Price
94.75
Daily Change
-1.63 -1.69%
Monthly
5.83%
Yearly
1.60%
Q2 Forecast
98.91

Revvity reported $253.88M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Agilent USD 476M 48M Dec/2025
Align Technology USD 465.34M 23.67M Mar/2026
Bio Techne USD 109.34M 4.35M Mar/2026
Bio-Rad Laboratories USD 221M 14.2M Dec/2025
Bruker USD 242.1M 5.1M Mar/2026
Celltrion KRW 12.71B 237.27B Dec/2025
Charles River Laboratories USD 159.42M 36.71M Mar/2026
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Danaher USD 1.86B 166M Mar/2026
Dentsply International USD 351M 32M Mar/2026
Deva Holding AS TRY 462.26M 48.18M Sep/2023
Dianthus Therapeutics USD 6.57M 1.62M Dec/2025
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Edwards Lifesciences USD 522.2M 80.7M Mar/2026
Illumina USD 272M 11M Mar/2026
Intuitive Surgical USD 613.3M 73.8M Mar/2026
IQVIA Holdings USD 502M 34M Mar/2026
Kangmei Pharma CNY 274.41M 15.05M Sep/2025
Knight Therapeutics CAD 35.45M 4.43M Dec/2025
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Laboratory Of America USD 551M 12.4M Mar/2026
Malin Corporation EUR 1.1M 400K Dec/2024
Medical Developments International AUD 2.84M 4.19M Dec/2025
Mesa Laboratories USD 27.31M 380K Sep/2024
Mettler Toledo International USD 258.33M 1.5M Mar/2026
Myriad Genetics USD 122.3M 6.7M Dec/2025
Neuren Pharmaceuticals AUD 3.74M 2.5M Dec/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Organigram Holdings CAD 7.73M 1.13M Dec/2025
Ovoca Bio EUR 632K 2.33M Jun/2025
Pacific Biosciences Of California USD 37.24M 25.68M Dec/2025
Pharma Mar EUR 15.31M 2M Mar/2026
Qiagen NV USD 153.88M 10.77M Dec/2025
Quest Diagnostics USD 504M 0 Mar/2026
Quidel USD 199.3M 4.9M Mar/2026
Repligen USD 76.54M 2.17M Mar/2026
Revvity USD 253.88M 2.15M Mar/2026
Sartorius EUR 221.3M 500K Mar/2026
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
Tilray USD 24.85M 1.7M Sep/2025
Waters USD 394M 153.99M Mar/2026
Zealand Pharma A/S 91.81M 99.04M Dec/2025
Zz Pientze Pharmaceu CNY 214.31M 42.4M Mar/2026